EYEG - EyeGate Pharmaceuticals announces $8M private placement

EyeGate Pharmaceuticals ([[EYEG]] +5.9%) has entered into a securities purchase agreement in connection with a private placement with an affiliate of Armistice Capital, LLC for aggregate gross proceeds of ~$8M.EyeGate will issue to Armistice an aggregate of 1,531,101 shares of the its common stock, par value $0.01/share and warrants to purchase an aggregate of 1,531,101 shares, with a combined purchase price $5.225/Share and Warrant.Net proceeds to be used for supporting its operations, including for clinical trials, working capital and other general corporate purposes.Private Placement is expected to close on or about January 6, 2021.

For further details see:

EyeGate Pharmaceuticals announces $8M private placement